Management of tracheobronchial ulceration induced by high-dose brachytherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19324186.
- Also identified by DOI 10.1016/j.athoracsur.2008.08.045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The most severe complication of high-dose endobronchial brachytherapy is fatal hemoptysis. Intractable tracheobronchial ulceration due to high-dose endobronchial brachytherapy often develops into tracheobronchial necrosis and fatal hemoptysis. Our experience demonstrated that when bleeding from tracheobronchial ulcer, after high-dose endobronchial brachytherapy occurs, blocking the blood supply to the tracheobronchial ulcer alone is ineffective. Prophylactic tracheobronchial wrapping using the omentum should be added before the occurrence of fatal hemoptysis. This is the first report that describes an effective management for preventing fatal hemoptysis.
Medical subject headings
- Brachytherapy
- Bronchial Arteries
- Bronchial Diseases
- Carcinoma, Squamous Cell
- Lung Neoplasms
- Omentum
- Tracheal Diseases
- Ulcer